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Barrett's oesophagus is associated by an increased risk of oseophageal cancer, but its cell of origin is 1 
unclear. Here the authors show, using single-cell RNA sequencing of biopsies from 6 patients and 2 2 
unaffected subjects, that cells in Barrett's oesophagus show a transcriptional profile that is similar to 3 
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Barrett’s oesophagus is a precursor of oesophageal adenocarcinoma. In this common 35 
condition, squamous epithelium in the oesophagus is replaced by columnar epithelium in 36 
response to acid reflux. Barrett’s oesophagus is highly heterogeneous and its relationships to 37 
normal tissues are unclear. Here we investigate the cellular complexity of Barrett’s 38 
oesophagus and the upper gastrointestinal tract using RNA-sequencing of single cells from 39 
multiple biopsies from six patients with Barrett’s oesophagus and two patients without 40 
oesophageal pathology. We find that cell populations in Barrett’s oesophagus, marked by 41 
LEFTY1 and OLFM4, exhibit a profound transcriptional overlap with oesophageal 42 
submucosal gland cells, but not with gastric or duodenal cells. Additionally, SPINK4 and 43 
ITLN1 mark cells that precede morphologically identifiable goblet cells in colon and 44 
Barrett’s oesophagus, potentially aiding the identification of metaplasia. Our findings reveal 45 
striking transcriptional relationships between normal tissue populations and cells in a 46 
premalignant condition, with implications for clinical practice. 47 




At least 80% of cancers arise from epithelial cells. In many tumours a change in cell type, 50 
referred to as metaplasia, is a key step in cancer initiation. Barrett’s oesophagus (BO) is an 51 
example of metaplasia in the distal oesophagus and affects 1 in 50 people1. BO is defined as 52 
replacement of squamous epithelium by columnar epithelium, and it gives a 30-fold increased 53 
risk of developing oesophageal adenocarcinoma (OAC) which has a five year survival of 54 
only 15%2-4. BO is associated with gastro-oesophageal reflux disease, suggesting it occurs in 55 
response to a chronically inflamed environment5. Remarkably, several anatomically distant 56 
cell types are also identifiable in BO, most commonly intestinal goblet cells but also Paneth 57 
and pancreatic acinar cells, among others6-8.  58 
This apparent plasticity in BO has obscured its relationship with normal gastrointestinal (GI) 59 
tissues, as no normal GI tissue is as heterogeneous as BO. Several theories are proposed for 60 
the origin of BO. A widely held view is that BO originates from the stomach9,10, and studies 61 
looking for similarities (e.g. in gene or protein expression and cellular appearance) between 62 
BO and selected normal tissues - including the intestine, gastric pylorus, gastric corpus and 63 
gastric cardia – have found some shared attributes11,12. There is also evidence suggesting BO 64 
may originate directly from native oesophageal squamous13 or submucosal gland cells14-17, 65 
from recruitment of circulating stem cells18, or from reactivation of dormant p63-/KRT7+ 66 
residual embryonic cells (RECs) in situ19. In contrast to p63-/KRT7+ RECs, a recent study 67 
identified p63+/KRT5+/KRT7+ cells derived from the squamocolumnar junction as the cells 68 
of origin of BO in a transgenic mouse model with ectopic expression of CDX2 in KRT5+ 69 
epithelium20. Many of the proposed BO origin theories are based on transgenic mouse 70 
studies, and the submucosal gland cell theories are based on human histopathology studies. 71 
Unfortunately, submucosal gland theories cannot be tested in mice since mice and humans 72 
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have key differences in their gastrointestinal anatomy, and rodents lack oesophageal glands21. 73 
These difficulties argue for an unbiased and systematic genetic approach to BO 74 
characterisation in humans with all relevant control cell types to better understand the origin 75 
of BO cell types. 76 
Single cell RNA-sequencing (RNA-seq) combined with computational methods for 77 
functional clustering of cell types provides a less biased approach to understanding cellular 78 
heterogeneity. Given the highly heterogeneous nature of BO, we hypothesise that single cell 79 
RNA-seq might clarify the relationships between cells in normal tissues and BO, and indicate 80 
whether there are specialised cells in BO with similar functions to cells elsewhere in the 81 
gastrointestinal tract. Therefore we apply this approach to biopsies from BO, normal 82 
oesophagus, stomach and small intestine (duodenum). This reveals a cell population in BO 83 
that expresses the developmental gene (LEFTY1) and is distinct from intestinal or gastric 84 
cells, but has a highly similar RNA composition to columnar gene expressing cells from 85 
oesophageal submucosal glands in normal oesophagus.  86 
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Results  87 
Single cell RNA-seq identifies subpopulations in normal upper GI epithelia 88 
To characterise the cell populations in BO, samples were taken from 13 BO patients (A-D, I-89 
Q) attending for routine endoscopic surveillance of non-dysplastic BO. From each patient, we 90 
took biopsies from BO, adjacent macroscopically normal oesophagus (20mm proximal to 91 
BO), stomach (20mm distal to the gastro-oesophageal junction) and duodenum (Figure 1a). 92 
Individual 2mm biopsies were divided to provide tissue for single cell RNA-seq, bulk tissue 93 
RNA-seq and histology in 4 out of 13 patients, and bulk tissue RNA-seq and histology alone 94 
in the remaining 9 patients (see Methods). Single cells and histology were also prepared 95 
from normal oesophageal biopsies from two patients with gastro-oesophageal reflux disease 96 
but no previous or current diagnosis of BO or any other oesophageal pathology. All sampled 97 
patients were taking regular acid suppression therapy and had no features of oesophageal 98 
dysplasia or malignancy (Supplementary Table 1).  99 
Bulk RNA-sequencing followed by hierarchical clustering of differentially expressed genes 100 
in the duodenal, gastric, oesophageal and BO samples from 13 patients with BO showed a 101 
clear distinction between squamous (i.e. normal oesophagus) and non-squamous (i.e. gastric, 102 
duodenum and BO) epithelia (Figure 1b). BO samples from all 13 patients had some 103 
similarities to duodenal and gastric samples (Figure 1b). When a defined list of genes known 104 
to distinguish gastrointestinal epithelia12 was used in hierarchical clustering, BO samples 105 
appeared most closely related to gastric tissue, consistent with previous studies22 (Figure 1c).  106 
For single cell RNA-seq, a total of 4237 cells were sequenced from 8 patients 107 
(Supplementary Table 1) in three batches. Due to known issues with batch effects in single 108 
cell experiments23, analysis of cells from each batch has been kept separate where feasible 109 
and cells were permuted across plates and pooled prior to sequencing (see Methods). The 110 
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first batch yielded 1040 cells (207 duodenum, 227 gastric, 371 BO and 235 oesophagus) 111 
suitable for analysis from four patients (A-D) with BO and intestinal metaplasia. A total of 112 
214, 35, 66 and 56 BO cells were analysed from each BO patient, respectively. The second 113 
batch yielded 648 oesophagus cells suitable for analysis from two patients (E-F) with 114 
symptoms of gastro-oesophageal reflux but no identifiable oesophageal pathology. Finally, 115 
the third batch of cells yielded 194 cells (29 pylorus, 109 gastric, 32 BO and 24 oesophagus) 116 
suitable for analysis from two patients (G-H) with BO and intestinal metaplasia. Overall, 117 
there was a mean of 1.2x105 gene counts per cell and a median of 3978 genes were detected 118 
per cell (with at least one count per gene). 119 
First, we clustered the cells from each normal tissue type from the BO patients by gene 120 
expression (Figure 1d). The eleven clusters (D1-D4, G1-G3 and O1-O4, in duodenum, 121 
gastric and oesophageal samples, respectively) were then annotated on the basis of genes 122 
previously characterized as expressed in specific cell types (complete list in Supplementary 123 
Data 1). In the duodenum, these are: intestinal alkaline phosphatase (ALPI)-expressing 124 
enterocytes (D1); mucin 2 (MUC2)-expressing goblet cells (D2); olfactomedin 4 (OLFM4)-125 
expressing crypt cells (D3); and some uncharacterized cells expressing Joining Chain Of 126 
Multimeric IgA And IgM (JCHAIN) (D4). In the gastric samples, these are: chromogranin 127 
(CHGA)-expressing enteroendocrine cells (G1); gastrokinin (GKN1)- and trefoil factor 1 128 
(TFF1)-expressing foveolar cells (G2); and mucin 6 (MUC6)- and TFF1-expressing mucus 129 
neck cells (G3). Of note, the proton pump gene ATP4A and the intrinsic factor gene GIF were 130 
rarely detectable in gastric cells, indicating these are cardiac-type gastric samples 131 
(Supplementary Fig. 1). 132 
Interestingly, four clusters were identified in the oesophageal samples. Two of these express 133 
expected squamous genes (KRT5, KRT14, TP63; clusters O1 and O2) and two express the 134 
columnar gene TFF3 (clusters O3 and O4). The two squamous clusters can be distinguished 135 
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by the presence (O1) or absence (O2) of acute phase response (SAA1) gene expression, 136 
presumably representing squamous cells in different states. The detection of TFF3 in O3 and 137 
O4 is of great interest and is consistent with these cells being from the columnar epithelium 138 
of oesophageal submucosal glands (OSGs)24, a structure in the normal human oesophagus. To 139 
validate this, we used samples of normal oesophagus taken from the proximal part of an 140 
oesophagectomy specimen following resection for a Siewert type III junctional tumour to 141 
illustrate the structure of OSGs, OSG ducts and squamous epithelium (Figure 1e). Since 142 
OSGs comprise different cell lineages, including squamous lineages, we detected cytokeratin 143 
14 (KRT14, a squamous cell marker)-expressing cells in OSG ducts, demonstrating they are 144 
bona fide OSGs. Using the adjacent sections from the same OSG-containing specimen, we 145 
observed TFF3 and keratin 7 expression in OSG structures exclusively (Figure 1f). These 146 
results show that single cell transcriptomic analysis can identify gastrointestinal epithelial cell 147 
subpopulations, including cells from OSGs that cannot be distinguished by conventional bulk 148 
RNA-seq.  149 
Barrett’s oesophagus is enriched for LEFTY1-expressing cells 150 
To identify genes characteristic of distinct BO cell populations we clustered all the BO cells 151 
by gene expression (Figure 2a, also see Supplementary Data 1). The clusters (B1-B4) can 152 
be distinguished by expression of MUC2 (B1; goblet cells, 19% of BO cells); LEFTY1 (B2 153 
and B3, 71% of BO cells); and CHGA (B4; enteroendocrine cells, 9.7% of BO cells). Since 154 
all patients had intestinal metaplasia, goblet cells made up 22%, 2.9%, 29% and 7.1% of cells 155 
in patient A-D, respectively. KRT7 is expressed similarly across all 4 clusters, consistent with 156 
it being a marker of BO25,26. The LEFTY1-expressing cells (B2 and B3; Figure 2a) are 157 
divided into a larger, low proliferating (MKI67 (Ki67) negative) cluster (B2) and a smaller, 158 
high proliferating (MKI67 positive) cluster (B3). LEFTY1, a secreted protein and 159 
transforming growth factor beta (TGF-β) superfamily member, is normally expressed in 160 
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development, where it has roles in left-right asymmetry determination27, but little is known 161 
about its potential roles in adult tissues and it has not previously been associated with BO.  162 
To confirm the above finding and to further characterise LEFTY1 expression, we first 163 
examined MUC2, LEFTY1 and CHGA expression in sections generated from the same BO 164 
resection specimen. LEFTY1 expression was detected in BO epithelial cells (Supplementary 165 
Data 2). Interestingly, morphologically identifiable goblet cells are positive for MUC2 but 166 
not LEFTY1 or CHGA (Figure 2b).  167 
To further characterise LEFTY1 expression, we stained 140 BO samples from 80 patients, 78 168 
endoscopic biopsies from control sites (oesophagus, gastric fundus and duodenum) in 26 BO 169 
patients, and additionally five endoscopic samples from the pylorus, five resected samples of 170 
normal colon and five samples of normal oesophagus taken from the proximal part of an 171 
oesophagectomy specimen resected for junctional tumours (Supplementary Data 2). Overall 172 
there are two different LEFTY1 staining patterns: intensely positive cytoplasmic staining and 173 
moderate cytoplasmic staining. Moderate LEFTY1 staining only, was seen in the Brunner’s 174 
gland of the duodenum and in the lower portion of the glands in the gastric fundus. In the 175 
colon there are a few, intensely positively LEFTY1 staining cells. Both moderate and 176 
intensely expressing LEFTY1 cells are present in the gastric pylorus and BO 177 
(Supplementary Fig. 2). Immunohistochemical staining of oesophageal samples showed that 178 
the squamous epithelium was negative for LEFTY1 staining, as were the OSGs in 179 
oesophagectomy samples from non-BO patients. All three OSGs from the 140 oesophageal 180 
samples showed moderate cytoplasmic staining throughout the OSG (Figure 2c). These 181 
expression patterns explain why the more superficial mucosal biopsies obtained for single 182 
cell RNA-seq show dramatic differences in LEFTY1 expression between tissues.  183 
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OSGs share an RNA composition profile with Barrett’s oesophagus 184 
Taking all cells from BO patients together (A-D), the normal tissue cells separate clearly 185 
from the BO cells based on their gene expression, with the exception of specialised cell types 186 
such as goblet or enteroendocrine cells, but the majority of BO cells overlap with a sub-set of 187 
oesophageal cells, as seen in a t-Distributed Stochastic Neighbor Embedding (t-SNE) plot 188 
(Figure 3a). Clustering by gene expression (by the same method as in Figure 1d) assigned 189 
cells to 7 clusters (with brain controls in a separate cluster) (Figure 3b, c, also see 190 
Supplementary Fig. 3a). Most of these clusters are similar to those identified in the analysis 191 
of normal tissue alone (Figure 1d) and they can be related to known cell types based on 192 
expression of previously characterised genes (Supplementary Fig. 3b, also see 193 
Supplementary Data 3 for complete list). The majority of duodenal cells fall in the cluster 194 
categorised as ‘enterocytes’ (similar to D1), gastric as ‘mucus neck’ (similar to G3), and a 195 
substantial proportion of oesophageal cells are in the ‘squamous’ cluster (similar to O1/O2) 196 
(Figure 3c). Some oesophageal cells, BO cells and a few duodenal cells fall into a ‘goblet’ 197 
cluster, and some gastric cells cluster with a few BO cells in the ‘enteroendocrine’ cluster. 198 
The group described as ‘non-epithelial’ contains some endothelial cells and CD45-low 199 
immune cells (Supplementary Fig. 4). Notably, the majority of BO cells (63%) are in the 200 
cluster labelled as ‘Barrett’s-type’ that also contains the subset of oesophageal cells that have 201 
a gene expression profile consistent with their being OSGs (Figure 3c, also see 202 
Supplementary Data 3). These cells are enriched for LEFTY1 expression. 203 
To test whether this relationship between BO and native oesophageal cells with columnar 204 
characterisation was also seen in patients without BO, we clustered all normal oesophageal 205 
cells from patients with and without BO (A, B, D and E, F, respectively). This showed that 206 
cells grouped into five clusters (Supplementary Fig. 5a), three clusters (1, 2 and 4) were 207 
mainly squamous and the remaining two (3 and 5) had more columnar marker-expressing 208 
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cells. Of the ‘columnar’ clusters, cluster 5 consisted of cells from patients A and B and 209 
cluster 3 consisted of cells from patients B, D and E (patients A, B, D had BO, patients E, F 210 
had no BO) (Supplementary Fig. 5b). Although rare in these data, it is interesting that one 211 
of the clusters (cluster 3) containing TFF3+ cells also had four cells which were positive for 212 
the squamous genes KRT14 (a gene pair with KRT5), TP63 and KRT7 (Supplementary Fig. 213 
5c). As p63+ KRT7+ cells have been shown to generate intestinal-like epithelial cells in 214 
organoid culture upon CDX2 overexpression, it may be possible that these oesophageal cells 215 
could be related to the transitional zone progenitor cells previously observed in humans21. 216 
To confirm whether the relationship between BO cells and OSGs was stronger than the 217 
associations with other gland-type cells, we looked across the RNA compositions of cells 218 
from other tissues, i.e. gastric gland cells and BO cells that did not express CHGA or MUC2 219 
(to exclude enteroendocrine and goblet cells, respectively; see Methods for thresholding), 220 
and oesophageal cells that expressed TFF3 (to exclude squamous cells, Supplementary Fig. 221 
5d-e). We also developed BEARscc, an algorithm which uses external controls to simulate 222 
technical replicates to check whether a single cell clustering method is robust to technical 223 
variability28. The ‘score’ metric of BEARscc reflects how frequently cells within a group 224 
cluster together, as opposed to with cells from other clusters. We compared manually selected 225 
groups of 1) gastric and BO cells, 2) gastric and OSG cells, and 3) BO and OSG cells, from 226 
patients with BO (A-D). The BO and OSG cell combination had a higher score than any 227 
combination which included gastric cells, or all cells grouped together, suggesting BO and 228 
OSG cells have the most stable cell type relationship (Figure 3d). Using only these manually 229 
selected gastric, BO and OSG cells with additional OSG cells from patients without BO (E-230 
F), unbiased clustering with SC3 also confirmed the strong relationship between BO and 231 
OSG cells, with only very few gastric cells clustering with BO or OSG cells (Supplementary 232 
Fig. 6a). t-SNE, with the inclusion of duodenal cells which expressed the highest levels of 233 
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MUC6 to enrich for duodenal Brunner’s gland-type cells (Supplementary Fig. 6b), also 234 
confirmed the strong relationship between BO and OSG cells (Supplementary Fig. 6c). This 235 
relationship was characterised by high LEFTY1 expression (Supplementary Fig. 6d). Only a 236 
small number of genes show differential expression between BO cells and OSG cells that did 237 
not express CHGA and MUC2 (to exclude enteroendocrine and goblet cells). Pathway 238 
analysis on these genes did not suggest any biological processes that mechanistically 239 
distinguish BO and OSG cells (Supplementary Fig. 6e-f). 240 
In view of the phenotypic overlap with BO and gastric pylorus, we analysed the 241 
transcriptomes of 194 cells from an additional two patients (G-H) with BO (24 oesophageal 242 
cells, 32 BO cells, 109 gastric cardia cells and 29 gastric pyloric cells). Clustering of these 243 
cells on global and specific gene expression show that gastric cardia and pylorus exhibited 244 
similar RNA composition properties (Supplementary Fig. 7). The BO cells also expressed 245 
several of the gastric genes, but showed differences such as increased KRT7 and BPIFB1 246 
expression (Supplementary Fig. 7b). Collectively, these data show that oesophageal cells 247 
expressing genes seen in OSGs, and not intestinal, gastric or squamous cells, have the 248 
greatest RNA composition similarity to BO cells.  249 
ITLN1 and SPINK4 mark early goblet cells 250 
In this study, 19% of BO cells were classified as ‘goblet’ cells, which is consistent with the 251 
requirement in some countries, such as the US29, for goblet cells to be present for the 252 
diagnosis of BO. Goblet cells are classically defined by morphological appearance and 253 
MUC2 expression. Applying a threshold set at the tenth centile to include 90% of cells in 254 
which at least one transcript was detected from each gene of interest (to reduce biological 255 
noise), we found that MUC2 RNA co-expressed with intelectin 1 (ITLN1) and Kazal type 4 256 
serine peptidase inhibitor (SPINK4) in 61% of goblet cells from duodenum, gastric and BO 257 
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samples (Figure 4a-b). ITLN1 and SPINK4 have been previously shown to mark goblet cells 258 
in the normal gut and some non-gastrointestinal tissues30,31, but we observed some cells in 259 
each tissue type that uniquely expressed MUC2, ITLN1 or SPINK4. Therefore we 260 
hypothesized that their expression pattern might mark stages of goblet cell development in 261 
vivo. To test this, we analysed expression of these proteins by immunofluorescence staining 262 
of five human colon samples (approximately 500 crypts examined in each sample). ITLN1 263 
and SPINK4 co-staining was consistently present near the crypt base, where undifferentiated 264 
cells occur, whereas MUC2 staining was in cells toward the centre and top of the crypts, 265 
where terminally differentiated cells are found (Figure 4c). This suggests that ITLN1 and 266 
SPINK4 might mark an earlier stage of goblet cell differentiation than MUC2 in the intestine.  267 
In the three patients with OSGs found in the 140 squamous endoscopic biopsies from 80 268 
patients with BO, we observed that OSG cells consistently co-expressed ITLN1, and MUC2, 269 
but not SPINK4. This may be because SPINK4 positive cells are more ‘naïve’ in goblet cell 270 
differentiation and thus they are present lower in the duct or gland and were not captured 271 
within these biopsies (Figure 4d). In these same three patients we found a squamous marker 272 
(KRT14, which pairs with KRT5 in p63+ cells), a columnar marker (KRT7) and a specialised 273 
goblet cells marker (MUC2) expressed in adjacent cells in the same OSG (Figure 4e). This 274 
intestinal metaplasia in an OSG from a squamous oesophageal biopsy 20mm proximal to the 275 
BO margin suggests the ability of OSGs to undergo intestinalisation and may be the source of 276 
BO islands32. In 30 BO endoscopic mucosal resection (EMR) specimens (from 16 patients) 277 
with intestinal metaplasia but no dysplasia present, we also consistently observed cells 278 
expressing ITLN1 or SPINK4 without MUC2 (Figure 4f, also see Supplementary Table 2). 279 
Specifically, quantification of triple immunofluorescence staining of eight BO EMR 280 
specimens with intestinal metaplasia but no dysplasia taken from five patients showed 41% 281 
of MUC2 low cells expressed SPINK4 and/or ITLN1, whereas 28% of cells expressed MUC2 282 
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alone (Supplementary Table 3). These data suggest that OSGs and BO may contain early 283 
goblet cells, as seen in the colon, and that ITLN1 or SPINK4 might mark cells with some 284 
goblet cell characteristics that are not yet morphologically identifiable as goblet cells. 285 
OLFM4 marks a stem-like transcript profile in BO and OSG epithelium  286 
StemID is a published workflow designed to find cells with stem-like properties in single cell 287 
RNA-seq data by calculating a ‘stem-ness’ score based on the entropy of cell clusters and the 288 
number of links between clusters33,34. As a control we analysed duodenum cells from BO 289 
patients (A-D) and found the highest scoring cluster was enriched for LGR5 expression, 290 
consistent with LGR5 being a known marker of intestinal stem cells35,36. Applying StemID to 291 
the remaining individual tissues from the same patients did not identify any well-known stem 292 
cell markers (Supplementary Fig. 8a-b), even though a small number of LGR5 positive cells 293 
are present in all tissues sequenced (Supplementary Fig. 1). Since a recent study showed 294 
that BO contains pluripotent cells37 and in view of the striking transcript profile overlap 295 
between OSG and BO cells, we therefore analysed all BO and OSG cells using StemID 296 
(patients A-F). Interestingly, the highest scoring cluster was enriched for the stem-cell 297 
associated gene OLFM4 (Figure 5a, blue asterisk). BO cells from all four patients with BO 298 
(A-D) contributed to this cluster, and oesophageal cells from two patients with BO (A and B) 299 
(Supplementary Fig. 8c). The second highest scoring cell cluster (Figure 5a, red asterisk) 300 
was enriched for LYZ, a marker of Paneth cells, which are long-lived secretory cells found 301 
adjacent to the stem cell niche in the intestinal crypt base. OLFM4 has been shown to 302 
associate with LGR5 expression and marks stem cells in intestinal tissue in normal and 303 
metaplastic contexts38,39.  Consistent with this, immunohistochemical staining detected 304 
OLFM4 expression in human colon crypt bases, where stem cells are known to be located 305 
(Figure 5b). In 8 BO sections from 7 patients, we observed that OLFM4 protein expression 306 
was less restricted to the crypt base (Figure 5c), similar to previous observations of LGR5 307 
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expression patterns in BO12 and in contrast to the expression of OLFM4 in control tissues 308 
(Supplementary Fig. 8d). In OSGs beneath normal squamous epithelium, OLFM4 positive 309 
cells were seen within the gland structures (Figure 5d). Interestingly, OLFM4 staining in 310 
OSGs from patients without BO was much more restricted than seen in OSGs taken from 311 
patients with BO (Figure 5d, e), although the number of cases examined is limited. 312 
Notably, OLFM4 has a higher mean expression in the LEFTY1-positive clusters (B2/B3) 313 
compared to the clusters expressing known markers of the differentiated goblet (MUC2) and 314 
enteroendocrine (CHGA) lineages (Figure 2a, B1 and B4, respectively). To examine co-315 
expression of OLFM4, LEFTY1, MUC2 and CHGA in individual cells, we applied a threshold 316 
at the tenth centile to include 90% of cells in which at least one transcript was detected from 317 
each gene of interest. Using this threshold, half of the BO cells express LEFTY1 and OLFM4, 318 
alone or in combination (29% OLFM4 and LEFTY1; 13% OLFM4 only; 11% LEFTY1 only). 319 
LEFTY1 and OLFM4 positive BO cells rarely co-expressed MUC2 or CHGA 320 
(Supplementary Fig. 8e). Together, these data suggest that B2/B3 represent a cell population 321 
that harbours BO progenitor cells.  322 




Our single cell RNA-seq data has resolved cell sub-populations in gastrointestinal epithelia 325 
and shown a profound similarity in the transcript profile between OSG cells and BO cells. 326 
This is supported by our observation that this sub-population of BO cells and OSGs express 327 
the stem cell-associated gene OLFM4, in line with the notion that these populations might 328 
contain similar progenitor cells. Glandular epithelial cells are replaced by squamous 329 
epithelium during development of the oesophagus and OSGs are functionally important 330 
structures formed from remaining glandular epithelium40. It is thus not surprising that the 331 
developmental gene LEFTY1 is expressed in OSGs, and that as these structures expand 332 
during the development of BO, increased levels of LEFTY1 and OLFM4 are observed in 333 
these tissues. Notably, LEFTY1 is regulated by TGF-β signalling and bone morphogenic 334 
proteins (BMPs)41,42. Since TGF-β is often perturbed in BO, and BMPs have been shown to 335 
play a major role in the development of a BO like phenotype, it will be interesting to explore 336 
these relationships further43,44. 337 
Additionally, our findings support a previously proposed hypothesis that BO may originate 338 
from OSGs. This model suggests that acid and bile reflux-induced damage to the oesophagus 339 
is ‘repaired’ by the expansion or selection of OSGs, which contain progenitors that may 340 
express OLFM4 and have alkaline secretions, and are thus able to play a role in protecting the 341 
oesophagus from gastro-oesophageal reflux damage. Further consideration of the functional 342 
overlap of other secretory structures with BO and OSGs, such as salivary and mammary 343 
glands may help our understanding of an adaptive response to injury that drives metaplasia. 344 
Studies are also needed to experimentally demonstrate the potential of OSG cells, p63+ or 345 
p63- OSGs in particular, to develop into BO cells and OAC.  346 
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Given that rodents lack OSGs, and the lack of an in vitro model of human oesophageal 347 
glands, analysis of human biopsies currently provides the most reliable approach to dissect 348 
the cell relationships of BO. Future improvements in single cell sequencing techniques may 349 
enable more systematic genetic confirmation of the cellular origin of BO through DNA 350 
analysis and also allow higher throughput, to reduce any potential selection bias inherent in 351 
the methodology we have used, especially with respect to gastric cells, which were likely to 352 
have been detrimentally affected by acid exposure. Also, it is important to note that our study 353 
cannot definitively identify the origins of OAC. Future studies are needed to address the 354 
relationship between BO and OAC on a cellular level, and how this relates to recent work 355 
suggesting that OAC is highly similar to a sub-set of gastric cancers45. 356 
Finally we showed that SPINK4 and ITLN1 seem to identify an earlier stage of intestinal 357 
metaplasia than marked by MUC2, given that they are expressed lower in intestinal crypts 358 
than MUC2 and can be seen without MUC2 in BO. Of clinical importance, our results 359 
suggest that intestinal goblet cell characteristics exist even in the absence of morphologically 360 
identifiable goblet cells, supporting the view that diagnosis of BO should not require the 361 
detection of goblet cells. Together, our findings help characterize BO in humans. In addition, 362 
this study demonstrates the power of single cell analysis of clinical samples to uncover 363 









Patients attending routine endoscopic surveillance of BO and patients with mild reflux 371 
symptoms undergoing gastroscopy for diagnostic purposes gave written informed consent 372 
and provided samples (patients A-F and I-Q, study authorised by South Central - Oxford C 373 
Research Ethics Committee: 09/H0606/5+5; patients G-H, study authorised by Yorkshire & 374 
The Humber - Sheffield Research Ethics Committee: 16/YH/0247). Patient numbers were 375 
chosen to provide suitable biological replicates, and cells sequenced to provide balanced 376 
sample sizes at sequencing input. Double bite quadrantic 2mm biopsies were obtained 377 
endoscopically using standard biopsy forceps (Radial Jaw 4 Standard Capacity, Boston 378 
Scientific, Natick, USA) from a central region of the BO segment avoiding the proximal BO 379 
margin as well as the oesophagogastric junction. Control samples were taken from the second 380 
part of the duodenum, the stomach 20mm distal to the gastro-oesophageal junction and the 381 
normal oesophageal squamous epithelium at least 20mm clear of the most proximal extent of 382 
BO. Each sample was fragmented and then pooled to ensure all sampling sites were 383 
represented in each investigative modality. Fragments pools were divided into three groups 384 
for histological verification, whole-tissue RNA-seq and single cell RNA-seq (Figure 1a). 385 
Patients were selected based on their previously known pathological features 386 
(Supplementary Table 1 and Supplementary Fig. 9). Patients without BO described 0-2 387 
reflux episodes per week with normal endoscopic appearances of the upper gastrointestinal 388 
tract on endoscopic examination, and no histological evidence of oesophagitis in the 389 
processed samples. 390 
Cell isolation 391 
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Sample fragments were placed directly into a digestion solution (made with 1x phosphate 392 
buffered solution (Gibco™), 2mM EDTA, 100U ml-1 type I collagenase (Worthington 393 
Biochemical Company®), sodium phosphate (5.6mM), monopotassium phosphate (8mM), 394 
sodium chloride (96mM), potassium chloride (1.6mM), sucrose (44mM), D-Sorbitol 395 
(55mM), Dl-Dithiotreitol (0.5mM)) and gently oscillated at 4°C for 60 minutes. Samples 396 
were then further fragmented with scissors and briefly manually triturated with a p1000 397 
pipette. Fragments were allowed to settle and the cell-containing supernatant filtered (Sysmex 398 
Celltrics® 100 micron) into a 15ml Falcon tube. This process was repeated 3 times and the 399 
product centrifuged at 300g for 20 minutes at 4°C to create a cell pellet which was 400 
resuspended in sorting buffer (1x phosphate buffered solution (Gibco™), 2mM EDTA and 401 
5% heat inactivated fetal bovine serum (Sigma-Aldrich®)). A small amount of each sample 402 
was pooled for labelling controls. Pre-conjugated CD45-FITC (1:10, mouse monoclonal, cat. 403 
130-080-202, Miltenyi Biotec)46 and EpCAM-PE (1:10, mouse monoclonal, cat. 130-110-404 
999, Miltenyi Biotec)47 antibodies were added to cell suspensions to help identify epithelial 405 
and immune cells, respectively, and they were incubated/washed according to manufacturer’s 406 
advice. DAPI (1:2000, Sigma-Aldrich®) was added to cell suspensions immediately prior to 407 
sort. FACS was carried out using a BD Biosciences FACS Aria IIIu platform with 70μm 408 
nozzle in the case of the first four patients and the additional squamous samples, and a Sony 409 
SH800S Cell Sorter with 100μm chip in the second batch of two patients including the 410 
pyloric samples. Cells were selected based on size and singlet gating to saturate cell output 411 
while minimising debris passed to subsequent gates. Size and singlet gating were then 412 
adjusted to capture of EpCAM+ cells, on the basis that these would represent a range of 413 
epithelial cells and minimise debris selection (Supplementary Fig. 10a). Resultant cells 414 
were sorted directly into 96 well plates (Life Technologies™ MicroAmp® Optical 96-well 415 
Reaction Plate) pre-prepared with 2μl 0.2% Triton™ X-100 (Sigma-Aldrich®) and RNAse 416 
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inhibitor (Takara Recombinant RNase Inhibitor) at 19:1 and then immediately frozen on dry 417 
ice. To confirm spectral accuracy, compensation bead controls and pooled cell suspensions 418 
were used for fluorescence-minus-one controls where possible. Each plate was re-permuted 419 
to avoid batch effects at the next stages of preparation, with no single plate containing cells 420 
from only a single patient or tissue type. Variable patterns of 6 blank wells were also 421 
prepared in each plate, 3 of which had a 10pg of brain total RNA (Agilent Technologies) 422 
added as a positive control. A single 100 cell pool was also sorted in experiments involving 423 
pyloric cells (patients G-H) to provide a bulk control as whole tissue RNA-seq was not 424 
performed in these patients. To check for bias in cell selection, index sorting was carried out 425 
in most experiments to analyse expression of antibodies in relation to tissue type and 426 
subsequent data quality (Supplementary Fig. 10b-d). Using the input metrics available up to 427 
the point of sequencing, logistic regression was also undertaken to see if higher quality cell 428 
data could be predicted before sequencing. While the length of the experiment tended 429 
towards having an effect on data quality, recorded metrics at FACS could not accurately 430 
predict whether a cell would meet a read count threshold (Supplementary Fig. 10d).  431 
Single cell RNA-seq 432 
Transcriptome libraries were prepared using a Biomek FX liquid handling instrument 433 
(Beckman Coulter) with a custom adaptation of the published smart-seq2 method48,49, with 434 
minor modifications, and Nextera XT (Illumina®) methodology with custom, unique index 435 
primers after tagmentation and ERCC spike-in at a dilution of 1:100,000. Libraries were 436 
sequenced using the Illumina® HiSeq 4000 platform, aiming for 3.5x105 reads per cell at 437 
75bp paired end. 438 
Bulk RNA-seq 439 
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Tissue fragments were processed using the mirVana™ miRNA Isolation Kit (ThermoFisher) 440 
according to manufacturer’s guidance. Total RNA was enriched using ribodepletion (Ribo-441 
Zero, Illumina®) prior to cDNA conversion. Second strand DNA synthesis incorporated 442 
dUTP.  cDNA was end-repaired, A-tailed and adaptor-ligated. Samples then underwent 443 
uridine digestion. The prepared libraries were size-selected and multiplexed before 75bp 444 
paired end sequencing using the Illumina® HiSeq 4000 platform. 445 
Data analysis 446 
All data were mapped using STAR50 (release 2.5.2a) to the hg19 version of the human 447 
genome with transcriptome annotations from Gencode (release 25). Counts tables were made 448 
with HTSeq51. Cells were excluded that didn’t meet a threshold set to exclude all negative 449 
controls and outliers, and includes all remaining positive controls, see Supplementary Fig. 450 
11a-c). For example, this was fewer than 25,119 fragments mapping to the transcriptome in 451 
the first experiment (patients A-D). No oesophageal cells from patient C passed this quality 452 
control threshold. To check biological relevance, counts from the most abundant cell 453 
population from a single patient and tissue were summed and correlated against bulk RNA-454 
seq expression (Supplementary Fig. 11d). Counts were trimmed mean of M-values (TMM)-455 
normalised and fragments per kilobase million (FPKM) values were calculated. Genes with 456 
less than 4 FPKM in at least 3 cells were filtered out. After re-normalisation, expression 457 
values were converted to transcripts per kilobase million (TPM). A further gene filtering step 458 
was included to remove highly expressed genes with low variability across all samples (cells 459 
in the top decile for mean expression and below the fifth centile for coefficient of variation). 460 
SC352 was used to provide cell cluster information. Cluster robustness to experimental 461 
technical variation was tested using BEARscc28 which models technical noise from ERCC 462 
spike-in measurements. Cluster number, k, was chosen manually using the distribution of 463 
cluster-wise mean silhouette widths across clusters in all 250 simulated technical replicates 464 
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for each cluster number k (2 to 8 for individual tissue and 1 to 15 for all tissues). Where box 465 
plots are used, the lower and upper hinges correspond to the first and third quartiles (the 25th 466 
and 75th percentiles), the whiskers extend from the hinge to the largest or smallest values at 467 
most 1.5 x inter-quartile range from the hinge. Data beyond the whiskers are outliers and are 468 
plotted individually. t-SNE data were generated using the Barnes-Hut implementation of t-469 
SNE53 in R. Differential expression analysis was carried out between cell groups using 470 
edgeR54 from normalized counts according to the package manual. P values used were 471 
determined by permutation test at 5% (250-1000 permutations) to allow for multiple 472 
comparisons or, in cases of unbalanced sample numbers, converted to false discovery rates 473 
(FDR) by the Benjamini-Hochberg procedure. Pathway analysis was performed using goseq55 474 
to identify over or under represented ontological terms. Identification of stem-like cells was 475 
performed using RaceID2 and StemID, please see https://github.com/dgrun/StemID for more 476 
details33,34. Further results from this analysis showing differentially expressed genes in high 477 
stem-scoring clusters are available in Supplementary Data 4. Where gene expression is 478 
described in binary terms, the threshold was set to include or exclude 90% of cells with the 479 
highest expression of a given gene, to allow for biological noise. 480 
Immunohistochemistry and immunofluorescence on human tissue 481 
Oesophageal samples from oesophagectomy specimens (5 patients) containing normal 482 
mucosa and gland structures and endoscopic mucosal resection specimens (30 patients) with 483 
Barrett’s oesophagus were obtained from the Oxford Radcliffe and Translational 484 
Gastroenterology Unit biobanks. Sections were de-waxed, rehydrated and incubated with 3% 485 
hydrogen peroxide in methanol to block endogenous peroxidase activity (10 minutes, room 486 
temperature). Antigen retrieval was carried out using 10mM sodium citrate, pH6 at 100°C for 487 
10 minutes. Sections were then blocked with normal goat serum (at room temperature) and 488 
incubated overnight at 4 °C with a primary antibody against anti-KRT14 (IHC, 1:1000, rabbit 489 
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polyclonal, cat. PRB-155P, BioLegend), anti-TFF3 (IHC, 1:1000, mouse monoclonal, cat. 490 
WH0007033M1, Sigma-Aldrich®)56, anti-MUC2 (IHC, 1:300, rabbit polyclonal, cat. SC-491 
15334, Santa Cruz Biotechnology)57, anti-CHGA (IHC, 1:500, rabbit polyclonal, cat. 492 
ab15160, Abcam)58, anti-KRT7 (IHC, 1:4000, rabbit monoclonal, cat. ab181598, Abcam)59, 493 
anti-LEFTY1 (IHC, 1:1000, D7E3G rabbit polyclonal, cat. 12647, Cell Signalling), anti-494 
OLFM4 (IHC, 1:200, D1E4M rabbit monoclonal, cat. 14369, Cell Signalling Technology®), 495 
anti-ITLN1 (IHC/IF, 1:500, sheep polyclonal, cat. AF4254, R&D systems)60, anti-MUC2 (IF, 496 
1:300, mouse monoclonal, cat. ab11197, Abcam)61 or anti-SPINK4 (IF, 1:500, rabbit 497 
polyclonal, cat. HPA007286, Sigma-Aldrich®)62. For immunohistochemical staining, 498 
samples were then treated with biotinylated secondary antibody (Vector Labs; 1:250) for 40 499 
minutes at room temperature. The staining reaction was worked up using the Vector Elite 500 
ABC kit and counterstained with haematoxylin. Samples were examined by a pathologist 501 
using a histology microscope. For immunofluorescent staining, expression was detected using 502 
Alexa Fluor (1:250, Molecular Probes) for one hour. DAPI (1:2000, Sigma-Aldrich®) was 503 
used to stain nucleic acids. Samples were observed using a confocal microscope system 504 
(LSM 710; Carl Zeiss). The limited amount of material obtained from patients precluded the 505 
use of each described staining technique on every sample collected. 506 
Data availability 507 
Single cell and bulk RNA-seq counts data and the cell cluster assignments for each analysis 508 
are supplied in the Supplementary Data Files 5-7. Raw data are available in the European 509 
Genome-phenome Archive, following the necessary consents to protect donor anonymity 510 
(accession # EGAS00001003144). All other data available upon request. 511 
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Figure 1. Single cell RNA sequencing identifies cell groups in normal upper 682 
gastrointestinal epithelia 683 
(a) Endoscopic sampling sites (yellow, oesophagus; green, gastric cardia; purple, duodenum; 684 
orange, Barrett’s oesophagus) with summary of how tissues from patients were used. 2-4 685 
biopsies were taken at each site. Patients without BO were sampled from the lower 686 
oesophagus 20mm proximal to the squamous-columnar junction. (b) From bulk RNA-seq 687 
data derived from samples from 13 patients with BO, heatmap of genes differentially 688 
expressed between any tissue type (analysis of variance-like test, false discovery rate (FDR) 689 
< 1x10-12) with tissue hierarchy determined by nearest neighbour. Tissue indicated by colours 690 
as in a. One duodenal sample from patient Q failed to produce usable data and was excluded. 691 
(c) From bulk RNA-seq data, heatmap of expression of mucin and trefoil factor genes with 692 
tissue hierarchy determined by nearest neighbour, in samples from 13 patients with BO. (d) 693 
Upper panels show the cluster consensus matrices for single cells from normal tissue sites in 694 
four BO patients. Blue-to-red colours denote the frequency with which cells are grouped 695 
together in 250 repeat clusterings of simulated technical replicates (see Methods). Cell 696 
clusters are indicated by coloured bars below the matrices. In lower panels, heatmaps show 697 
expression of known functionally relevant genes that were differentially expressed between 698 
cell clusters (>4 fold change, FDR <1e-5). (e) Haematoxylin and eosin staining of normal 699 
oesophagus taken from the proximal part of an oesophagectomy specimen resected for 700 
Siewert type III junctional tumour in a patient with no BO, showing OSGs (red arrow), OSG 701 
ducts (black arrow) and squamous epithelium (marked with dotted black line). Scale bar 702 
500µm. (f) Immunohistochemical staining of KRT14, TFF3 and KRT7 (left, middle and right 703 
images, respectively) in adjacent sections from the same specimen as e, showing OSG ducts 704 
(black arrows) and OSGs (red arrows) and squamous epithelium (marked with dotted black 705 




Figure 2. LEFTY1 and OLFM4 are mainly expressed in Barrett’s oesophagus cells that 708 
do not express differentiated secretory cell markers 709 
 (a) Upper panel, cluster consensus matrix of BO cells from 4 BO patients (n=371 cells). 710 
Blue-to-red colours denote the frequency with which cells are grouped together in 250 repeat 711 
clusterings of simulated technical replicates (see Methods). Clusters (B1-B4) are indicated 712 
by the coloured bars below. Lower panel, heatmaps showing expression of selected 713 
functionally relevant genes that are differentially expressed between cell clusters (>4 fold 714 
change, FDR <1e-5). (b) Immunohistochemical staining of MUC2, LEFTY1 and CHGA in 715 
sections derived from the same BO resection specimen. Black arrows indicate goblet cells on 716 
all sections (positively stained for MUC2; negative for LEFTY1 and CHGA) Scale bars are 717 
50µm. (c) Immunohistochemical staining of LEFTY1 in an OSG from a normal squamous 718 
endoscopic biopsy obtained from a patient with BO. Scale bars are 300µm and 50µm in 719 
enlarged image. 720 
 721 
Figure 3. The majority of Barrett’s oesophagus cells have a similar transcript profile to 722 
oesophageal submucosal gland (OSG) cells 723 
(a) t-Distributed Stochastic Neighbour Embedding (t-SNE) plots of cells from all samples 724 
from four BO patients (n=1107 including brain control), showing similarity of cells in two 725 
dimensions, coloured by tissue type (yellow, oesophagus; green, gastric cardia; purple, 726 
duodenum; orange, Barrett’s oesophagus; pink, brain). Brain was used as a control. (b) t-SNE 727 
plot of cells from four BO patient samples (A-D), as in a, coloured by how cells contribute to 728 
clusters generated by SC3 analysis with 250 repeat clusterings of simulated technical 729 
replicates (see Methods). Names given to the clusters are based on expression of known 730 
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marker genes (see text and Supplementary Fig. 3). (c) Sankey diagram showing how each 731 
tissue type sampled contributes to the clusters shown in b. Colours and labels on the left 732 
indicate sampled tissue (as in a); colours and labels on the right indicate cluster (as in b). (d) 733 
Mean BEARscc score for each grouping of ‘gland-like’ cells (n=372), which are a sub-set of 734 
gastric (G, n=175), BO (n=78) and OSG cells (n=119): excluding gastric and BO cells that 735 
expressed CHGA or MUC2 (to exclude enteroendocrine and goblet cells, respectively) and 736 
excluding oesophageal cells that did not express TFF3 (to exclude squamous cells). 737 
‘Ensemble’ refers to all cells grouped together. Thresholds were set at the tenth centile of 738 
cells in which at least one transcript was detected from each gene of interest. 739 
 740 
Figure 4. SPINK4 and ITLN1 mark early goblet cells 741 
(a) Volcano plot showing fold change and p value of genes differentially expressed in the 742 
‘goblet-type’ cell cluster as compared to all other cell clusters (see Figure 3). Points coloured 743 
red indicate genes significant at 5% permutation test. Selected highly significant genes are 744 
labelled. (b) Bar chart showing the percentage of cells in the ‘goblet-type’ cell cluster (n=98) 745 
expressing MUC2, ITLN1 or SPINK4 alone or in different combinations (thresholds set at the 746 
tenth centile to include 90% of cells in which at least one transcript was detected from each 747 
gene). (c) Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and 748 
SPINK4 (green) in normal colon from a resection specimen (blue stain is DAPI). Scale bar 749 
100µm. (d) Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and 750 
SPINK4 (green) in normal oesophageal epithelium obtained by endoscopic biopsy (blue stain 751 
is DAPI). OSGs encroaching on the surface epithelium are shown in the enlarged images on 752 
the right. Scale bars are 200µm and 50µm in enlarged images. (e) Triple immunofluorescence 753 
staining images of KRT14 (white), KRT7 (green) and MUC2 (red) in an OSG beneath 754 
normal squamous epithelium from an endoscopic biopsy of normal squamous epithelium 755 
31 
 
from a patient with BO biopsy (blue stain is DAPI). Scale bar 50µm. (f) Representative 756 
immunofluorescence staining of Barrett’s EMR specimen containing intestinal metaplasia but 757 
no dysplasia for MUC2 (red), ITLN1 (white) and SPINK4 (green); nuclei (DAPI) in blue. 758 
Scale bars are 400µm and 100µm in enlarged images. 759 
 760 
Figure 5. OLFM4 is upregulated in BO and OSG cells with stem-like transcript profiles 761 
(a) Bar plot on left shows StemID scores across all RaceID2 clusters (see Methods) applied 762 
to all non-squamous oesophageal cells (BO and oesophageal cells with <5 KRT14 counts to 763 
exclude squamous cells, n=533). Scores are calculated from multiplication of the entropy 764 
(spread from the cluster mean) and the number of cluster links arising from a given cluster. 765 
Differentially expressed genes in the highest scoring cluster (C3, blue asterisk) and second 766 
highest scoring cluster (C7, red asterisk) are shown in the volcano plots in the centre and 767 
right plots, respectively. Points coloured red indicate the most significant genes with a fold 768 
change greater than 2. Selected highly significant genes are labelled. (b) 769 
Immunohistochemical staining of OLFM4 in human colon (close-up of base of crypt inset). 770 
Scale bars are 100µm and 20µm in inset. (c) Immunohistochemical staining of OLFM4 in 771 
BO mucosal resection containing intestinal metaplasia but no dysplasia, with enlarged image. 772 
Scale bars are 1000µm, 200µm in enlarged image and 50µm in inset. (d) 773 
Immunohistochemical staining of OLFM4 in OSG under normal oesophagus taken from the 774 
proximal part of an oesophagectomy specimen resected for Siewert type III junctional tumour 775 
in a patient with no BO. Red dashed area and arrow indicates OSG, black arrow indicates 776 
OSG duct. Scale bars are 300µm and 20µm in enlarged image. (e) Immunohistochemistry in 777 
OSGs from endoscopic biopsy of normal squamous oesophagus in patients with BO. Scale 778 
bars are 300µm and 50µm in enlarged image. 779 
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